Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Cancers|September 9, 2022
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple MyelomaAnna Fregnani, Lara Saggin, Ketty Gianesin, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 3, 2015
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic LeukemiaAndrea Visentin, Monica Facco, Federica Frezzato, et al.
Medical Oncology (Northwood, London, England)|July 15, 2026
DLBCL-microenvironment interactions: cytokine profiling and ECM-mediated ibrutinib resistance in a 3D bone-based modelJessica Ceccato, Maria Piazza, Giulia Gualtiero, et al.
Plos One|October 3, 2013
Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cellsSabrina Manni, Alessandra Brancalion, Elisa Mandato, et al.
British Journal of Haematology|April 19, 2017
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cellsVeronica Martini, Cristina Gattazzo, Federica Frezzato, et al.
Cancers|November 13, 2021
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic LeukemiaFederica Frezzato, Andrea Visentin, Filippo Severin, et al.
Cancer Reports (Hoboken, N.J.)|April 25, 2024
When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a "rare in rare" scenarioNicolò Danesin, Greta Scapinello, Dorella Del Prete, et al.
Scientific Reports|May 2, 2025
A model workflow for microfluidic enrichment and genetic analysis of circulating melanoma cellsCristina Poggiana, Alessandro Francesco Piazza, Cristina Catoni, et al.
Oncotarget|January 19, 2017
Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathwaysSabrina Manni, Marilena Carrino, Martina Manzoni, et al.
Frontiers in Oncology|July 2, 2021
Treatment Induced Cytotoxic T-Cell Modulation in Multiple Myeloma PatientsGregorio Barilà, Laura Pavan, Susanna Vedovato, et al.
Pageof 18